Analysis on severe fever with thrombocytopenia syndrome bunyavirus infection combined with atrial fibrillation under digital model detection

Lin, Ting‐Tse; Yi, Yinping; Shan, Yu; Yu, Dan; Zhang, Jing; Qu, Yongsheng; Qin, Qingzhu; Pei, Yongju; Zhang, Hongmei; Chen, Daniel; Kaddouri, Meriem; Omar, Khairi Mohamed

doi:10.1016/j.rinp.2021.104413

Cited by 2 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It was feasible to use ECG to monitor stress in the workplace [ 80 ]. After surgery, patients were more satisfied with ECG monitoring for atrial fibrillation than observation [ 81 ].…”

Section: Resultsmentioning

confidence: 99%

Noninvasive monitoring technologies to identify discomfort and distressing symptoms in persons with limited communication at the end of life: a scoping review

Xu,

Smaling,

Schoones

et al. 2024

BMC Palliat Care

View full text Add to dashboard Cite

Background Discomfort and distressing symptoms are common at the end of life, while people in this stage are often no longer able to express themselves. Technologies may aid clinicians in detecting and treating these symptoms to improve end-of-life care. This review provides an overview of noninvasive monitoring technologies that may be applied to persons with limited communication at the end of life to identify discomfort. Methods A systematic search was performed in nine databases, and experts were consulted. Manuscripts were included if they were written in English, Dutch, German, French, Japanese or Chinese, if the monitoring technology measured discomfort or distressing symptoms, was noninvasive, could be continuously administered for 4 hours and was potentially applicable for bed-ridden people. The screening was performed by two researchers independently. Information about the technology, its clinimetrics (validity, reliability, sensitivity, specificity, responsiveness), acceptability, and feasibility were extracted. Results Of the 3,414 identified manuscripts, 229 met the eligibility criteria. A variety of monitoring technologies were identified, including actigraphy, brain activity monitoring, electrocardiography, electrodermal activity monitoring, surface electromyography, incontinence sensors, multimodal systems, and noncontact monitoring systems. The main indicators of discomfort monitored by these technologies were sleep, level of consciousness, risk of pressure ulcers, urinary incontinence, agitation, and pain. For the end-of-life phase, brain activity monitors could be helpful and acceptable to monitor the level of consciousness during palliative sedation. However, no manuscripts have reported on the clinimetrics, feasibility, and acceptability of the other technologies for the end-of-life phase. Conclusions Noninvasive monitoring technologies are available to measure common symptoms at the end of life. Future research should evaluate the quality of evidence provided by existing studies and investigate the feasibility, acceptability, and usefulness of these technologies in the end-of-life setting. Guidelines for studies on healthcare technologies should be better implemented and further developed.

show abstract

“…It was feasible to use ECG to monitor stress in the workplace [ 80 ]. After surgery, patients were more satisfied with ECG monitoring for atrial fibrillation than observation [ 81 ].…”

Section: Resultsmentioning

confidence: 99%

Noninvasive monitoring technologies to identify discomfort and distressing symptoms in persons with limited communication at the end of life: a scoping review

Xu,

Smaling,

Schoones

et al. 2024

BMC Palliat Care

View full text Add to dashboard Cite

show abstract

“…SFTS is an infectious disease discovered in 2010, caused by a novel Bunyavirus, with diverse clinical manifestations and lack of specificity ( Dualis et al, 2021 ; Chaudhuri et al, 2022 ; Zhu et al, 2022 ). When neurological and psychiatric symptoms accompanied by multi-organ dysfunction occur, the disease progresses rapidly with a poor prognosis ( Wu et al, 2016 ; Oh et al, 2017 ; Li et al, 2021 ; Tao et al, 2021 ). Therefore, identifying laboratory differences between ordinary and critically ill patients and promptly providing antimicrobial and immune-enhancing therapies can significantly improve patient survival rates.…”

Section: Discussionmentioning

confidence: 99%

Clinical value of coagulation parameters in predicting the severity of severe fever with thrombocytopenia syndrome

Xia,

Jia,

Chen

et al. 2024

Front. Microbiol.

View full text Add to dashboard Cite

IntroductionSevere fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by a novel bunyavirus infection with a high lethality rate. The purpose of this study was to investigate the changes in coagulation parameters in patients with SFTS, aiming to provide clinical evidence for early diagnosis, treatment, and disease analysis.MethodsA total of 40 patients with SFTS attended from April 1, 2020 to May 21, 2022 in Nanjing Drum Tower Hospital were selected and grouped according to the duration of the disease, mild and severe disease, cure and death, with 50 healthy physical examiners as controls, and the risk of severe and death disease was predicted using ROC curves.ResultsComparison between the healthy, mild and severe groups revealed that PT, INR, APTT, TT, D-D and vWF levels were higher than those in the healthy control group, and FII, FIX, FX, FXI, FXII, PC and PS levels were lower than those in the healthy control group, the differences were statistically significant (p < 0.05). Comparing the results of SFTS patients with different course times, the results of Fib, FV, FVII, FVIII, FIX, FX, FXI were statistically significant (p < 0.05). Among the survived and deceased patients, the PT, INR, DD and PS results of the deceased patients were higher than those of the survived patients, and the FVIII, FIX, FXI, FXII and PC were lower than those of the survived patients. The area under the ROC curve showed that D-D had higher predictive ability for the risk of severe disease (AUROC 0.93, sensitivity and specificity at a Cut-off value of 1.50 mg/L were 90.0 and 86.5%, respectively) and the risk of death occurring (AUROC 0.84, sensitivity and specificity at a Cut-off value of 3.39 mg/L were 87.5 and 80.0%, respectively).DiscussionThe monitoring of the coagulation parameters in patients with SFTS is great significance for identifying the severity and death of the patient’s condition, and it is of great clinical value to provide early attention, timely intervention and maximum reduction of the mortality rate for patients at risk of severe disease.

show abstract

Analysis on severe fever with thrombocytopenia syndrome bunyavirus infection combined with atrial fibrillation under digital model detection

Cited by 2 publications

References 17 publications

Noninvasive monitoring technologies to identify discomfort and distressing symptoms in persons with limited communication at the end of life: a scoping review

Noninvasive monitoring technologies to identify discomfort and distressing symptoms in persons with limited communication at the end of life: a scoping review

Clinical value of coagulation parameters in predicting the severity of severe fever with thrombocytopenia syndrome

Contact Info

Product

Resources

About